A new weapon in the treatment of non-Hodgkin's lymphoma.
Lipcamon
James D
JD
Department of Radiology, Jennie Edmundson Memorial Hospital, Council Bluffs, Iowa, USA. jlipcamon@nmhs.org
Sahl
Becky
B
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007204:Indium / Q000008:administration & dosage; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy*; D009566:Nitrates / Q000008:administration & dosage; D016499:Radioimmunotherapy / Q000009:adverse effects / Q000191:economics / Q000639:trends; D012051:Reimbursement Mechanisms; D000069283:Rituximab; D014481:United States
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D009566:Nitrates; D007204:Indium; D000069283:Rituximab; C422802:ibritumomab tiuxetan; C089767:indium nitrate